Phosphorylation of TSC2 (S1365) as a novel Regulator of mTORC1 Signaling in T Cells
Phosphorylation of TSC2 (S1365) as a novel Regulator of mTORC1 Signaling in T Cells
批准号:
10386765
负责人:
Erika L Pearce
金额:
$50.35万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-04-08 至 2026-03-31
关键词:
Adoptive Cell TransfersAttenuatedCD8-Positive T-LymphocytesCD8B1 geneCardiac MyocytesCell Differentiation processCell physiologyCellular biologyCuesCyclic GMP-Dependent Protein KinasesDevelopmentEffector CellEngineeringExhibitsFRAP1 geneGenerationsGeneticGoalsGuanosine Triphosphate PhosphohydrolasesHeartHeart DiseasesHeart failureHelper-Inducer T-LymphocyteHumanHyperactivityHypoxiaImmune signalingInfectionKnock-in MouseMalignant NeoplasmsMemoryMetabolicMusMutateMutationOutcomePathway interactionsPhenotypePhosphorylationPhosphorylation SitePlayProtein-Serine-Threonine KinasesProteinsReactive Oxygen SpeciesRegulationRestRoleSerineSignal PathwaySignal TransductionSiteStressT cell differentiationT-Cell ActivationT-Cell ReceptorT-LymphocyteTestingTuberous SclerosisViruscancer immunotherapyeffector T cellimprovedin vivoinsightmortalitymutantnovelpressurepreventtreatment strategytumortumor-immune system interactionsvaccine development
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
mTOR plays a critical role in integrating signals from the immune microenvironment to regulate T cell
activation, differentiation and function. We have been able to demonstrate that the Tuberous Sclerosis
Complex 2 (TSC2) protein plays an important role in regulating mTORC1 activation in T cells. TSC2 is a
RasGap protein that inhibits the activity of Rheb GTPase that in turn activates mTORC1. We have shown
that genetic deletion of TSC2 in T cells leads to enhanced mTORC1 activity and a marked increase in
CD8+ T cell effector function. However, while TSC2-/- T cells respond robustly to viruses and tumors, their
persistent mTORC1 activity leads to a decrease in memory CD8+ T cell generation. Recently, the Kass lab
has identified a novel phosphorylation site on TSC2 that regulates mTORC1 activity in cardiac myocytes.
Phosphorylation of this site (S1365) leads to the inhibition of mTORC1 signaling. Mutating this site(SA)
leads to an increase mTORC1 activity and the development of worse heart disease and mortality from
pressure-overload (PO) stress. Alternatively, creating a phosphomimetic (SE) at this site mitigates
mTORC1 activity and imparts protection from heart failure upon pressure overload. We hypothesized that
the TSC2 (S1365) site might play an important role in regulating mTORC1 activity in T cells. Our
preliminary studies demonstrate that upon TCR engagement this site is indeed phosphorylated. T cells
harboring the SA mutation have unaltered mTORC1 activity in the non-stimulated condition (unlike TSC2-/-
T cells), but show markedly increased activity upon TCR engagement. T cells with the SE mutation exhibit
the opposite. Furthermore, phosphorylation of TSC2 (S1365) is markedly induced by hypoxia, low pH and
reactive oxygen species suggesting that this pathway plays a critical role in integrating stress signals in
order to regulate T cell differentiation and function. In this project we seek to define and understand a novel
and selective mechanism of mTORC1 regulation in T cells. The overall goal of this proposal is to dissect
the mechanisms by which phosphorylation of TSC2 at S1365 regulates mTORC1 activation in T cells, and
consequently selectively regulates T cell activation, differentiation and function. Upon the completion of this
proposal our findings will help elucidate novel and critical mTORC1 regulatory signaling mechanisms in T
cells, and have implications for developing vaccines and engineering more robust T cells for Adoptive
Cellular Therapy. This may in turn result in improved treatment strategies for preventing and treating
infections as well as cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mitochondrial Membrane Dynamics in Th17 Cells
-
批准号:10733013
-
项目类别:
-
资助金额:$57.59万
-
财政年份:2023
-
负责人:Erika L Pearce
-
依托单位:
The Role of the Amino Acid Hypusine in the Maintenance and Function of Tissue-Resident Macrophages
-
批准号:10656730
-
项目类别:
-
资助金额:$53.0万
-
财政年份:2023
-
负责人:Erika L Pearce
-
依托单位:
Phosphorylation of TSC2 (S1365) as a novel Regulator of mTORC1 Signaling in T Cells
-
批准号:10596567
-
项目类别:
-
资助金额:$51.17万
-
财政年份:2021
-
负责人:Erika L Pearce
-
依托单位:
TUMOR-IMPOSED GLUCOSE RESTRICTIONS ON T CELLS DAMPEN IMMUNITY
-
批准号:8913080
-
项目类别:
-
资助金额:$22.41万
-
财政年份:2014
-
负责人:Erika L Pearce
-
依托单位:
TUMOR-IMPOSED GLUCOSE RESTRICTIONS ON T CELLS DAMPEN IMMUNITY
-
批准号:9337389
-
项目类别:
-
资助金额:$22.41万
-
财政年份:2014
-
负责人:Erika L Pearce
-
依托单位:
TUMOR-IMPOSED GLUCOSE RESTRICTIONS ON T CELLS DAMPEN IMMUNITY
-
批准号:9151813
-
项目类别:
-
资助金额:$22.41万
-
财政年份:2014
-
负责人:Erika L Pearce
-
依托单位:
TUMOR-IMPOSED GLUCOSE RESTRICTIONS ON T CELLS DAMPEN IMMUNITY
-
批准号:8759445
-
项目类别:
-
资助金额:$31.64万
-
财政年份:2014
-
负责人:Erika L Pearce
-
依托单位:
Targeting mTOR for Immunity to Cancer
-
批准号:8294536
-
项目类别:
-
资助金额:$16.53万
-
财政年份:2011
-
负责人:Erika L Pearce
-
依托单位:
Metabolic Regulation of CD8 T Cell Memory Development
-
批准号:8452685
-
项目类别:
-
资助金额:$35.72万
-
财政年份:2011
-
负责人:Erika L Pearce
-
依托单位:
Metabolic Regulation of CD8 T Cell Memory Development
-
批准号:8650256
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2011
-
负责人:Erika L Pearce
-
依托单位:
Targeting mTOR for Immunity to Cancer
-
批准号:8391001
-
项目类别:
-
资助金额:$12.16万
-
财政年份:2011
-
负责人:Erika L Pearce
-
依托单位:
Metabolic Regulation of CD8 T Cell Memory Development
-
批准号:8258242
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2011
-
负责人:Erika L Pearce
-
依托单位:
Metabolic Regulation of CD8 T Cell Memory Development
-
批准号:8183158
-
项目类别:
-
资助金额:$17.86万
-
财政年份:2011
-
负责人:Erika L Pearce
-
依托单位:
Targeting mTOR for Immunity to Cancer
-
批准号:8191188
-
项目类别:
-
资助金额:$12.37万
-
财政年份:2011
-
负责人:Erika L Pearce
-
依托单位:
Metabolic Regulation of CD8 T Cell Memory Development
-
批准号:8368081
-
项目类别:
-
资助金额:$23.56万
-
财政年份:2011
-
负责人:Erika L Pearce
-
依托单位:
海外基金